These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 11083646)

  • 1. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America.
    Tait-Kamradt A; Davies T; Appelbaum PC; Depardieu F; Courvalin P; Petitpas J; Wondrack L; Walker A; Jacobs MR; Sutcliffe J
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3395-401. PubMed ID: 11083646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
    Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage.
    Tait-Kamradt A; Davies T; Cronan M; Jacobs MR; Appelbaum PC; Sutcliffe J
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2118-25. PubMed ID: 10898684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study.
    Farrell DJ; Douthwaite S; Morrissey I; Bakker S; Poehlsgaard J; Jakobsen L; Felmingham D
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1777-83. PubMed ID: 12760848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae.
    Canu A; Malbruny B; Coquemont M; Davies TA; Appelbaum PC; Leclercq R
    Antimicrob Agents Chemother; 2002 Jan; 46(1):125-31. PubMed ID: 11751122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumococcal resistance to macrolides, lincosamides, ketolides, and streptogramin B agents: molecular mechanisms and resistance phenotypes.
    Edelstein PH
    Clin Infect Dis; 2004 May; 38 Suppl 4():S322-7. PubMed ID: 15127365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.
    Walsh F; Willcock J; Amyes S
    J Antimicrob Chemother; 2003 Sep; 52(3):345-53. PubMed ID: 12917252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in Germany.
    Reinert RR; Wild A; Appelbaum P; Lütticken R; Cil MY; Al-Lahham A
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2319-22. PubMed ID: 12821488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanism of macrolide-lincosamide resistance in Moraxella catarrhalis.
    Saito R; Nonaka S; Nishiyama H; Okamura N
    J Med Microbiol; 2012 Oct; 61(Pt 10):1435-1438. PubMed ID: 22820696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-specific mutations in the 23S rRNA gene of Helicobacter pylori confer two types of resistance to macrolide-lincosamide-streptogramin B antibiotics.
    Wang G; Taylor DE
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1952-8. PubMed ID: 9687389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolide resistance in Streptococcus pneumoniae: clonality and mechanisms of resistance in 24 countries.
    Bozdogan B; Bogdanovich T; Kosowska K; Jacobs MR; Appelbaum PC
    Curr Drug Targets Infect Disord; 2004 Sep; 4(3):169-76. PubMed ID: 15379728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibilities to telithromycin and six other agents and prevalence of macrolide resistance due to L4 ribosomal protein mutation among 992 Pneumococci from 10 central and Eastern European countries.
    Nagai K; Appelbaum PC; Davies TA; Kelly LM; Hoellman DB; Andrasevic AT; Drukalska L; Hryniewicz W; Jacobs MR; Kolman J; Miciuleviciene J; Pana M; Setchanova L; Thege MK; Hupkova H; Trupl J; Urbaskova P
    Antimicrob Agents Chemother; 2002 Feb; 46(2):371-7. PubMed ID: 11796344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquired resistance to macrolides in M. hominis.
    Pereyre S; Gonzalez P; De Barbeyrac B; Darnige A; Renaudin H; Charron A; Raherison S; Bébéar C; Bébéar CM
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3142-50. PubMed ID: 12234836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of macrolide resistance genes erm(B) and mef(A) among 160 penicillin-intermediate clinical isolates of Streptococcus pneumoniae isolated in southern France.
    Marchandin H; Jean-Pierre H; Jumas-Bilak E; Isson L; Drouillard B; Darbas H; Carrière C
    Pathol Biol (Paris); 2001 Sep; 49(7):522-7. PubMed ID: 11642013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of ribosome methylation in MLS-resistant Streptococcus pneumoniae by macrolides and ketolides.
    Zhong P; Cao Z; Hammond R; Chen Y; Beyer J; Shortridge VD; Phan LY; Pratt S; Capobianco J; Reich KA; Flamm RK; Or YS; Katz L
    Microb Drug Resist; 1999; 5(3):183-8. PubMed ID: 10566867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-kill study of the activity of telithromycin against macrolide-resistant Streptococcus pneumoniae Isolates with 23S rRNA mutations and changes in ribosomal proteins L4 and L22.
    Reinert RR; Al-Lahham A
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3011-3. PubMed ID: 15980387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominance of 23S rRNA mutants among non-erm, non-mef macrolide-resistant clinical isolates of Streptococcus pneumoniae collected in the United States in 1999-2000.
    Davies TA; Bush K; Sahm D; Evangelista A
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3031-3. PubMed ID: 15980393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study.
    Farrell DJ; Morrissey I; Bakker S; Felmingham D
    J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():39-47. PubMed ID: 12239227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A).
    Malhotra-Kumar S; Mazzariol A; Van Heirstraeten L; Lammens C; de Rijk P; Cornaglia G; Goossens H
    J Antimicrob Chemother; 2009 Jan; 63(1):42-6. PubMed ID: 18952616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of macrolide and/or lincosamide resistant Streptococcus pneumoniae clinical isolates with ribosomal mutations.
    Doktor SZ; Shortridge VD; Beyer JM; Flamm RK
    Diagn Microbiol Infect Dis; 2004 May; 49(1):47-52. PubMed ID: 15135500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.